- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07765381
A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated With Hormone Imbalance
This study evaluates the effects of the Love Wellness Hello Burn, Balance supplement on symptoms associated with hormone imbalance, as measured by energy levels and healthy eating choices and habits. The trial is a single-arm, open-label, virtual study conducted over 4 weeks, in which all 40 enrolled participants will take the test product daily.
Participants will complete self-reported questionnaires at Baseline, after First Use (within 1-3 hours of use), and at Weeks 1, 2, 3, and 4 to assess changes in symptoms associated with hormonal imbalance, energy levels, healthy eating choices and habits, metabolism, and overall product efficacy.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89101
- Citruslabs
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be female
- Be aged 25 or over
- Has in the past 4 weeks experienced issues regarding all of the following: difficulty making healthy eating choices and habits, hormonal-driven challenges with healthy eating choices and habits, self-perceived slow metabolism, and low energy
- Generally healthy - does not live with any uncontrolled chronic disease
- If taking oral over-the-counter supplements or herbal remedies targeted at hormone balance or energy, has been consistently taking these for at least 3 months prior to starting the study and is willing to maintain this routine for the study duration
- Willing to refrain from introducing any products or any new forms of prescription medication or supplements that target hormone balance or energy for the study duration
- Willing to maintain their diet, sleep schedule, and activity level for the duration of the study
- Not currently partaking in another research study and will not be partaking in any other research study for the next 4 weeks and at any point during this study's duration
- Resides in the United States
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone currently taking a prescription thyroid treatment (like levothyroxine)
- Anyone with known severe allergic reactions
- Anyone with any allergies or sensitivities to any of the study product ingredients
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
- Anyone diagnosed with diabetes (type I or type II)
- Anyone unwilling to follow the study protocol
- Has changed birth control in the past 3 months
- Anyone planning to undergo any surgeries or invasive treatments during the study duration
- Anyone who has had any major illness in the last 3 months
- Anyone with a history of substance abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hello Burn, Balance Supplement
|
All participants take 2 capsules of the Love Wellness Hello Burn, Balance supplement once daily in the morning with a glass of water during the first meal of the day for 4 weeks.
The supplement contains selenium (as L-selenomethionine) 55 mcg, chromium (as chromium polynicotinate) 35 mcg, Hello Burn Blend (L-carnitine tartrate, organic green tea leaf powder) 1250 mcg, hypromellose capsule, microcrystalline cellulose, and magnesium stearate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Symptoms Associated with Hormone Imbalance
Time Frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Assessed via self-reported questionnaire measuring participant-perceived symptoms associated with hormonal imbalance
|
Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Energy Levels
Time Frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Assessed via self-reported questionnaire measuring participant-perceived energy levels
|
Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
|
Change in Healthy Eating Choices
Time Frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Assessed via self-reported questionnaire measuring participant-perceived healthy eating choices and including stress eating
|
Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
|
Change in Perception of Metabolism
Time Frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Assessed via self-reported questionnaire measuring participant-perceived metabolic rate
|
Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
|
Product Efficacy Perception
Time Frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Assessed via self-reported questionnaire measuring participant perception of the test product's overall efficacy
|
Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20688
- legacy-20688
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.